IPOTracker
eToroTrade IPO stocks the day they listStart on eToro
All companies
Alamar Biosciences Inc logo

Alamar Biosciences Inc

ALMR
PublicArchived
Public / ArchivedUnited StatesUSUnited States(NASDAQ Global Select)Best valuation $1.58BSince IPO +34.00%1 market

Public listing

Listed· NASDAQ Global Select· Listing market: United StatesUS United States
Listing date
Apr 17, 2026
Final IPO price
$17.00
Shares offered
11,250,000
Offering proceeds
$191.25M

Sources: sec-harvest, nasdaq

IPO Calendar
IPO Calendar · NASDAQIPO
ALMR
Price
$22.78
24h
+3.73%
Valuation
$1.58B
24h volume
$5.87M
Type
IPO
IPO CalendarTrade Alamar Biosciences Inc

Now trading publicly. Buy via a broker — opens in a new tab.

Trade on IPO Calendar

IPO Calendar · updated 1h ago

Alamar Biosciences Inc IPO unlock schedule & public float

Lock-up schedule, public float and locked shares extracted from Alamar Biosciences Inc's SEC prospectus. Shares shown are eligible to trade — lock-up expiry does not mean holders have sold or will sell.

424B4Apr 17, 2026
Total shares (FD)
66.52M
Public float
11.25M
Locked
55.27M
IPO raise
$191.25M
Next unlock
Oct 14, 2026 · 55.27M
Shares eligible to trade · by holder groupApr 17, 2026 → Oct 14, 2026 · 100% unlocked
  • Lock-up holders55.27M
  • IPO public float11.25M

About Alamar Biosciences Inc

Alamar Biosciences Inc is a life-sciences tools company developing precision proteomics technology for biomarker discovery and disease research.

What the company does

  • Develops immunoassay and proteomics platforms intended to detect and analyze low-abundance proteins.
  • Serves researchers, biopharma companies, and clinical-development teams that need sensitive biological measurement tools.
  • Competes on assay sensitivity, throughput, workflow reliability, data quality, and adoption by research and translational-medicine customers.

Business profile

Alamar Biosciences sits in the life-sciences tools market, where platform performance, installed-base growth, consumables pull-through, and research-budget demand shape the business.

SEC IPO filings

Effective

EDGAR filings resolved from ALMR / CIK 0002104204.

424B4424B4
Apr 17, 2026Final prospectus0001193125-26-161647
S-1/AS-1/A
Apr 16, 2026Amended0001193125-26-158122
8-A12B8-A12B
Apr 15, 2026Exchange registration0001193125-26-156986
S-1/AS-1/A
Apr 13, 2026Amended0001193125-26-151891
S-1S-1
Mar 27, 2026Filed0001193125-26-129039
DRS/Afilename1.htm
Mar 12, 2026Confidential draft0001193125-26-104470
DRS/Afilename1.htm
Feb 17, 2026Confidential draft0001193125-26-054940
DRSfilename1.htm
Jan 9, 2026Confidential draft0001193125-26-009127

Latest Alamar Biosciences Inc IPO news

Recent sourced articles classified for IPO relevance, with platform-access noise filtered out where possible.

Form 8-K for Alamar Biosciences INC filed 05/08/2026
Alamar Biosciences, Inc. (Investor Relations)May 8, 2026IPO context

Alamar Biosciences filed a Form 8-K with a reported earliest event date of May 8, 2026. (Exact content is in the filing document and is recent relative to the company’s IPO.)

Alamar Biosciences Inc IPO — frequently asked questions

When did Alamar Biosciences Inc go public?
Alamar Biosciences Inc completed its IPO on Apr 17, 2026 on NASDAQ Global Select under the ticker ALMR and now trades publicly.
What was Alamar Biosciences Inc's IPO price?
Alamar Biosciences Inc priced its IPO at $17.00 per share.
Can I buy Alamar Biosciences Inc stock?
Yes — Alamar Biosciences Inc is publicly traded on NASDAQ Global Select as ALMR. You can follow its live price, valuation and post-IPO performance above.
What is Alamar Biosciences Inc's valuation?
Alamar Biosciences Inc's most recent valuation tracked here is $1.58B, derived from live market prices.